| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sheep | 34 | 2019 | 233 | 2.310 |
Why?
|
| Mesenchymal Stem Cells | 17 | 2018 | 183 | 1.950 |
Why?
|
| Retroviridae | 13 | 2012 | 28 | 1.750 |
Why?
|
| Cosmic Radiation | 3 | 2018 | 13 | 1.620 |
Why?
|
| Hematopoietic Stem Cells | 14 | 2020 | 103 | 1.580 |
Why?
|
| Transduction, Genetic | 7 | 2013 | 46 | 1.260 |
Why?
|
| Genetic Vectors | 16 | 2019 | 127 | 1.260 |
Why?
|
| Bone Marrow Cells | 9 | 2018 | 125 | 1.070 |
Why?
|
| Hemophilia A | 4 | 2013 | 26 | 1.060 |
Why?
|
| Cell Differentiation | 16 | 2018 | 484 | 1.000 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 11 | 2016 | 112 | 0.990 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 10 | 2013 | 83 | 0.960 |
Why?
|
| Stem Cells | 7 | 2018 | 331 | 0.930 |
Why?
|
| Models, Animal | 9 | 2014 | 198 | 0.910 |
Why?
|
| Fetus | 14 | 2016 | 91 | 0.890 |
Why?
|
| Factor VIII | 4 | 2013 | 25 | 0.850 |
Why?
|
| Animals | 40 | 2019 | 8544 | 0.770 |
Why?
|
| Regenerative Medicine | 2 | 2015 | 219 | 0.710 |
Why?
|
| Antigens, CD34 | 12 | 2019 | 60 | 0.700 |
Why?
|
| Hematopoiesis | 4 | 2018 | 33 | 0.700 |
Why?
|
| Gestational Age | 6 | 2014 | 134 | 0.680 |
Why?
|
| Gene Transfer Techniques | 6 | 2019 | 66 | 0.630 |
Why?
|
| Dendritic Cells | 2 | 2018 | 62 | 0.620 |
Why?
|
| Fetal Therapies | 1 | 2019 | 2 | 0.590 |
Why?
|
| Transgenes | 5 | 2008 | 52 | 0.590 |
Why?
|
| Weightlessness | 1 | 2018 | 9 | 0.570 |
Why?
|
| Immunity, Innate | 1 | 2018 | 83 | 0.540 |
Why?
|
| Splenomegaly | 1 | 2016 | 7 | 0.510 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 9 | 0.510 |
Why?
|
| Immune Tolerance | 4 | 2015 | 71 | 0.500 |
Why?
|
| Radiation Injuries | 1 | 2016 | 86 | 0.480 |
Why?
|
| Hematologic Diseases | 2 | 2015 | 25 | 0.470 |
Why?
|
| Humans | 47 | 2020 | 34474 | 0.450 |
Why?
|
| Stem Cell Transplantation | 5 | 2010 | 228 | 0.450 |
Why?
|
| Immunomodulation | 2 | 2013 | 32 | 0.430 |
Why?
|
| Pregnancy | 12 | 2019 | 1069 | 0.420 |
Why?
|
| Receptors, Virus | 2 | 2012 | 15 | 0.420 |
Why?
|
| Occupational Exposure | 1 | 2016 | 237 | 0.420 |
Why?
|
| Immunity, Humoral | 1 | 2013 | 15 | 0.410 |
Why?
|
| Dependovirus | 1 | 2013 | 20 | 0.400 |
Why?
|
| Hemarthrosis | 2 | 2011 | 4 | 0.400 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 30 | 0.400 |
Why?
|
| Antibodies, Viral | 1 | 2013 | 70 | 0.390 |
Why?
|
| Liver Regeneration | 2 | 2010 | 25 | 0.390 |
Why?
|
| Graft Survival | 7 | 2016 | 315 | 0.380 |
Why?
|
| Fetal Blood | 4 | 2018 | 38 | 0.370 |
Why?
|
| Cell Proliferation | 7 | 2018 | 628 | 0.360 |
Why?
|
| Uterus | 2 | 2019 | 106 | 0.360 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2019 | 13 | 0.360 |
Why?
|
| Fetal Diseases | 2 | 2004 | 19 | 0.350 |
Why?
|
| Mice | 7 | 2019 | 2691 | 0.340 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 1118 | 0.330 |
Why?
|
| Transplantation, Heterologous | 12 | 2015 | 123 | 0.320 |
Why?
|
| Blood Coagulation | 1 | 2009 | 20 | 0.310 |
Why?
|
| Liver Diseases | 1 | 2010 | 75 | 0.310 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 112 | 0.310 |
Why?
|
| Germ Cells | 1 | 2009 | 12 | 0.300 |
Why?
|
| Female | 18 | 2020 | 21490 | 0.280 |
Why?
|
| Antigen Presentation | 1 | 2008 | 10 | 0.280 |
Why?
|
| Stem Cell Niche | 3 | 2019 | 27 | 0.280 |
Why?
|
| DNA Damage | 2 | 2018 | 96 | 0.270 |
Why?
|
| Astronauts | 2 | 2018 | 8 | 0.270 |
Why?
|
| Bone Marrow | 6 | 2019 | 77 | 0.270 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 270 | 0.250 |
Why?
|
| Cytomegalovirus | 5 | 2014 | 31 | 0.250 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2013 | 165 | 0.250 |
Why?
|
| Cell Movement | 3 | 2012 | 180 | 0.240 |
Why?
|
| Proviruses | 1 | 2005 | 3 | 0.240 |
Why?
|
| Spermatozoa | 1 | 2005 | 30 | 0.230 |
Why?
|
| Recombinant Proteins | 4 | 2020 | 281 | 0.220 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 73 | 0.220 |
Why?
|
| Endothelial Cells | 3 | 2016 | 203 | 0.220 |
Why?
|
| Gene Expression Profiling | 2 | 2005 | 341 | 0.210 |
Why?
|
| Flow Cytometry | 7 | 2010 | 197 | 0.210 |
Why?
|
| Cells, Cultured | 10 | 2020 | 887 | 0.200 |
Why?
|
| Neoplasms | 1 | 2010 | 791 | 0.200 |
Why?
|
| Intestines | 2 | 2013 | 65 | 0.190 |
Why?
|
| Viral Proteins | 2 | 2013 | 35 | 0.190 |
Why?
|
| Bone Marrow Transplantation | 2 | 2016 | 68 | 0.180 |
Why?
|
| Kanamycin Kinase | 3 | 2012 | 6 | 0.180 |
Why?
|
| Apoptosis | 2 | 2016 | 400 | 0.170 |
Why?
|
| Liver | 5 | 2014 | 510 | 0.170 |
Why?
|
| Phenotype | 4 | 2011 | 656 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 5 | 2014 | 204 | 0.160 |
Why?
|
| Adult | 5 | 2020 | 10015 | 0.160 |
Why?
|
| Transplantation Chimera | 6 | 2007 | 22 | 0.160 |
Why?
|
| Erythropoiesis | 1 | 2020 | 7 | 0.160 |
Why?
|
| Multipotent Stem Cells | 1 | 2020 | 17 | 0.160 |
Why?
|
| Immunity | 1 | 2020 | 22 | 0.160 |
Why?
|
| Animals, Newborn | 1 | 2000 | 143 | 0.160 |
Why?
|
| Anemia | 1 | 2020 | 58 | 0.150 |
Why?
|
| Cell Communication | 1 | 2019 | 42 | 0.150 |
Why?
|
| Islets of Langerhans | 2 | 2010 | 79 | 0.150 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2019 | 30 | 0.150 |
Why?
|
| beta-Galactosidase | 5 | 2002 | 20 | 0.150 |
Why?
|
| Injections, Intraperitoneal | 4 | 2011 | 51 | 0.150 |
Why?
|
| Cell Lineage | 5 | 2013 | 71 | 0.150 |
Why?
|
| Transfection | 4 | 2005 | 216 | 0.150 |
Why?
|
| Consensus | 1 | 2019 | 91 | 0.140 |
Why?
|
| Bleomycin | 1 | 2018 | 13 | 0.140 |
Why?
|
| Prenatal Care | 1 | 2019 | 55 | 0.140 |
Why?
|
| Solar Energy | 1 | 2018 | 4 | 0.140 |
Why?
|
| Bystander Effect | 1 | 2018 | 6 | 0.140 |
Why?
|
| Protons | 1 | 2018 | 23 | 0.140 |
Why?
|
| Histones | 1 | 2018 | 53 | 0.140 |
Why?
|
| DNA Repair | 1 | 2018 | 57 | 0.140 |
Why?
|
| Hepatocytes | 4 | 2007 | 84 | 0.140 |
Why?
|
| RNA, Messenger | 6 | 2013 | 545 | 0.140 |
Why?
|
| Cytomegalovirus Infections | 2 | 2014 | 49 | 0.140 |
Why?
|
| Male | 6 | 2020 | 20697 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 281 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2012 | 103 | 0.130 |
Why?
|
| Iron | 1 | 2018 | 121 | 0.130 |
Why?
|
| Gene Expression | 5 | 2016 | 362 | 0.130 |
Why?
|
| Organ Specificity | 3 | 2006 | 86 | 0.130 |
Why?
|
| Body Burden | 1 | 2016 | 7 | 0.130 |
Why?
|
| Sheep, Domestic | 2 | 2016 | 19 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 302 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 180 | 0.120 |
Why?
|
| Blood Transfusion, Intrauterine | 1 | 2016 | 4 | 0.120 |
Why?
|
| Radiation Dosage | 1 | 2016 | 96 | 0.120 |
Why?
|
| Genome, Human | 1 | 2016 | 136 | 0.120 |
Why?
|
| Age Factors | 2 | 2009 | 1261 | 0.120 |
Why?
|
| Models, Biological | 2 | 2008 | 426 | 0.120 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 70 | 0.120 |
Why?
|
| Electromagnetic Fields | 1 | 2015 | 30 | 0.110 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 49 | 0.110 |
Why?
|
| Tissue Distribution | 2 | 2013 | 72 | 0.110 |
Why?
|
| Transplantation, Homologous | 3 | 2016 | 163 | 0.110 |
Why?
|
| Amniotic Fluid | 1 | 2015 | 86 | 0.110 |
Why?
|
| Stromal Cells | 2 | 2008 | 84 | 0.110 |
Why?
|
| DNA, Viral | 1 | 2014 | 57 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2013 | 268 | 0.100 |
Why?
|
| Neutralization Tests | 1 | 2013 | 13 | 0.100 |
Why?
|
| Capsid | 1 | 2013 | 9 | 0.100 |
Why?
|
| Immune Evasion | 1 | 2013 | 2 | 0.100 |
Why?
|
| Epitopes | 1 | 2013 | 27 | 0.100 |
Why?
|
| Luciferases | 1 | 2013 | 34 | 0.100 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 88 | 0.100 |
Why?
|
| Time Factors | 6 | 2009 | 2352 | 0.100 |
Why?
|
| Complement System Proteins | 1 | 2013 | 9 | 0.100 |
Why?
|
| Immediate-Early Proteins | 1 | 2013 | 10 | 0.100 |
Why?
|
| Viral Envelope Proteins | 1 | 2013 | 12 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 3 | 2004 | 98 | 0.100 |
Why?
|
| Transplantation, Autologous | 2 | 2015 | 104 | 0.100 |
Why?
|
| Receptor, EphB2 | 1 | 2013 | 4 | 0.100 |
Why?
|
| Glycoproteins | 1 | 2013 | 44 | 0.100 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 177 | 0.100 |
Why?
|
| Cell Line | 3 | 2012 | 476 | 0.100 |
Why?
|
| Base Sequence | 2 | 2010 | 264 | 0.090 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 75 | 0.090 |
Why?
|
| Genetic Engineering | 1 | 2012 | 21 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 45 | 0.090 |
Why?
|
| Killer Cells, Natural | 2 | 2012 | 28 | 0.090 |
Why?
|
| Isoantibodies | 1 | 2011 | 12 | 0.090 |
Why?
|
| Sus scrofa | 1 | 2011 | 49 | 0.090 |
Why?
|
| Remission Induction | 1 | 2011 | 97 | 0.090 |
Why?
|
| Antibody Specificity | 2 | 2008 | 19 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2012 | 328 | 0.090 |
Why?
|
| Insulin | 2 | 2010 | 394 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2011 | 109 | 0.080 |
Why?
|
| Thymus Gland | 2 | 2008 | 17 | 0.080 |
Why?
|
| Immunosuppression | 1 | 2010 | 120 | 0.080 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2009 | 6 | 0.080 |
Why?
|
| Coagulants | 1 | 2009 | 3 | 0.080 |
Why?
|
| Partial Thromboplastin Time | 1 | 2009 | 7 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 6 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 28 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 71 | 0.080 |
Why?
|
| Species Specificity | 1 | 2009 | 101 | 0.080 |
Why?
|
| Exons | 1 | 2009 | 53 | 0.080 |
Why?
|
| Blotting, Southern | 2 | 2000 | 24 | 0.080 |
Why?
|
| Epithelial Cells | 2 | 2008 | 148 | 0.080 |
Why?
|
| Sertoli Cells | 1 | 2009 | 6 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 389 | 0.070 |
Why?
|
| Docosahexaenoic Acids | 1 | 2009 | 25 | 0.070 |
Why?
|
| Lung | 2 | 2014 | 279 | 0.070 |
Why?
|
| DNA | 2 | 2010 | 235 | 0.070 |
Why?
|
| Autoantigens | 1 | 2008 | 16 | 0.070 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 16 | 0.070 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2008 | 8 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2008 | 35 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2007 | 8 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2009 | 215 | 0.060 |
Why?
|
| Middle Aged | 2 | 2020 | 12703 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 849 | 0.060 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2005 | 1 | 0.060 |
Why?
|
| Injections | 2 | 2007 | 76 | 0.060 |
Why?
|
| Fluorescent Dyes | 2 | 2019 | 54 | 0.060 |
Why?
|
| Testis | 1 | 2005 | 72 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 41 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2010 | 700 | 0.060 |
Why?
|
| Infusions, Parenteral | 1 | 2005 | 69 | 0.060 |
Why?
|
| Cell Survival | 2 | 2009 | 304 | 0.060 |
Why?
|
| Lac Operon | 2 | 2005 | 7 | 0.050 |
Why?
|
| Purkinje Fibers | 1 | 2004 | 3 | 0.050 |
Why?
|
| Fetal Heart | 1 | 2004 | 5 | 0.050 |
Why?
|
| Brain | 2 | 2014 | 1031 | 0.050 |
Why?
|
| Genes, Reporter | 2 | 2000 | 44 | 0.050 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2007 | 29 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 1010 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 772 | 0.050 |
Why?
|
| Mesoderm | 1 | 2002 | 13 | 0.050 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2002 | 5 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2002 | 9 | 0.050 |
Why?
|
| Immunophenotyping | 3 | 2009 | 51 | 0.050 |
Why?
|
| Risk Factors | 1 | 2009 | 4136 | 0.040 |
Why?
|
| Brazil | 1 | 2020 | 16 | 0.040 |
Why?
|
| Hematinics | 1 | 2020 | 6 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2020 | 49 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 124 | 0.040 |
Why?
|
| Erythropoietin | 1 | 2020 | 33 | 0.040 |
Why?
|
| Microtechnology | 1 | 2019 | 4 | 0.040 |
Why?
|
| Antigens, CD | 3 | 2008 | 106 | 0.040 |
Why?
|
| Kidney | 1 | 2002 | 528 | 0.040 |
Why?
|
| Gentamicins | 1 | 1998 | 5 | 0.040 |
Why?
|
| Erythroid Precursor Cells | 1 | 1998 | 2 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 593 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1998 | 44 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 378 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 142 | 0.030 |
Why?
|
| Cell Separation | 2 | 2009 | 93 | 0.030 |
Why?
|
| Patient Selection | 1 | 2020 | 291 | 0.030 |
Why?
|
| Ferrets | 1 | 2018 | 21 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 1997 | 27 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 934 | 0.030 |
Why?
|
| Endothelium, Vascular | 2 | 1997 | 163 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2009 | 118 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2016 | 29 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 25 | 0.030 |
Why?
|
| North Carolina | 1 | 2020 | 1612 | 0.030 |
Why?
|
| Chondrogenesis | 1 | 2015 | 20 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 27 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 74 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2015 | 81 | 0.030 |
Why?
|
| Fetal Development | 1 | 2014 | 27 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2014 | 44 | 0.030 |
Why?
|
| Virus Replication | 1 | 2014 | 43 | 0.030 |
Why?
|
| Secretory Vesicles | 1 | 2013 | 4 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 80 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2012 | 18 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 72 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2013 | 43 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 52 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2012 | 27 | 0.020 |
Why?
|
| Thrombin | 1 | 2012 | 26 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2012 | 14 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 1994 | 257 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 41 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 118 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 91 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 129 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 255 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2012 | 38 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2012 | 43 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 143 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 3812 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 92 | 0.020 |
Why?
|
| Reference Standards | 1 | 2010 | 34 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 834 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2009 | 7 | 0.020 |
Why?
|
| Mitosis | 1 | 2009 | 26 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 9 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2009 | 8 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2009 | 15 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 43 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 259 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2008 | 4 | 0.020 |
Why?
|
| Cell-Derived Microparticles | 1 | 2008 | 5 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 3618 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 214 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2008 | 6 | 0.020 |
Why?
|
| Antigens, CD7 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2008 | 7 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 13 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2008 | 21 | 0.020 |
Why?
|
| Clone Cells | 1 | 2007 | 37 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2008 | 86 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2010 | 529 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 755 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 10998 | 0.020 |
Why?
|
| Mitochondria | 1 | 2008 | 218 | 0.020 |
Why?
|
| Interleukin-1 | 2 | 1997 | 51 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 730 | 0.010 |
Why?
|
| K562 Cells | 1 | 2005 | 4 | 0.010 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2005 | 6 | 0.010 |
Why?
|
| Virus Integration | 1 | 2005 | 5 | 0.010 |
Why?
|
| Hela Cells | 1 | 2005 | 82 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2004 | 4 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 48 | 0.010 |
Why?
|
| Transplantation | 1 | 2004 | 13 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 55 | 0.010 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2004 | 6 | 0.010 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2004 | 5 | 0.010 |
Why?
|
| Brain Tissue Transplantation | 1 | 2004 | 3 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 44 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 97 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 155 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2004 | 208 | 0.010 |
Why?
|
| X Chromosome | 1 | 2002 | 27 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2002 | 41 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 79 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 139 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2001 | 22 | 0.010 |
Why?
|
| Antigens | 1 | 2001 | 36 | 0.010 |
Why?
|
| Immunization | 1 | 2001 | 40 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2001 | 50 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2000 | 18 | 0.010 |
Why?
|
| Granulocytes | 1 | 2000 | 13 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 529 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2000 | 69 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2000 | 59 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 1122 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 1354 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1997 | 15 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1997 | 64 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1997 | 52 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1997 | 89 | 0.010 |
Why?
|
| Child | 1 | 2002 | 2613 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 1994 | 23 | 0.010 |
Why?
|